Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Clinical trial NCT02907918 · TERMINATED
Trial details
- NCT number
- NCT02907918
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2020-08-24
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.